Sign In
Buy AERI
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie (AERI) Rises Despite Q4 Earnings Miss, Revenues Top Mark
11:23am, Monday, 01'st Mar 2021
Aerie (AERI) up more than 16% despite reporting a wider-than-expected loss in the fourth quarter of 2020. Revenues beat estimates.
Aerie Pharmaceuticals, Inc. (AERI) CEO Vince Anido on Q4 2020 Results - Earnings Call Transcript
01:35am, Friday, 26'th Feb 2021
Aerie Pharmaceuticals, Inc. (AERI) CEO Vince Anido on Q4 2020 Results - Earnings Call Transcript
Aerie Pharmaceuticals (AERI) Reports Q4 Loss, Tops Revenue Estimates
06:58pm, Thursday, 25'th Feb 2021
Aerie (AERI) delivered earnings and revenue surprises of -5.33% and 13.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
07:30am, Monday, 22'nd Feb 2021
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies
Aerie Pharmaceuticals' (AERI) CEO Vince Anido on Q3 2020 Results - Earnings Call Transcript
02:53am, Sunday, 08'th Nov 2020
Aerie Pharmaceuticals' (AERI) CEO Vince Anido on Q3 2020 Results - Earnings Call Transcript
Aerie Pharmaceuticals, Inc. (AERI) CEO Vicente Anido On Q3 2020 Results - Quick Version Earnings Call Transcript
08:29pm, Thursday, 05'th Nov 2020
Aerie Pharmaceuticals, Inc. (AERI) CEO Vicente Anido On Q3 2020 Results - Quick Version Earnings Call Transcript
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries
03:00am, Wednesday, 28'th Oct 2020
OSAKA, Japan & DURHAM, N.C.--(BUSINESS WIRE)--Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered in
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call on Thursday, November 5, 2020
07:30am, Tuesday, 27'th Oct 2020
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies f
Next Generation Cancer Diagnostics: Technologies and Global Markets (2019-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 25'th Aug 2020
The
New Strong Sell Stocks for August 10th
02:01pm, Monday, 10'th Aug 2020
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Aerie (AERI) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
02:53pm, Friday, 07'th Aug 2020
Aerie (AERI) posts a wider-than-expected loss and sales miss estimates in the second quarter of 2020.
Aerie Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
08:01pm, Thursday, 06'th Aug 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
